| Georgia Catherine Hay, MD | |
|
1205 Central Texas Expy, Lampasas, TX 76550-3388 | |
| (512) 565-5362 | |
| (512) 556-8004 |
| Full Name | Georgia Catherine Hay |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 15 Years |
| Location | 1205 Central Texas Expy, Lampasas, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801024054 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | N8104 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Standards Home Health | Round rock, TX | Home health agency |
| Seton Home Care | Burnet, TX | Home health agency |
| Encompass Home Health Of Central Texas | Marble falls, TX | Home health agency |
| Lee Healthcare Inc | Hamilton, TX | Home health agency |
| Ascension Seton Highland Lakes | Burnet, TX | Hospital |
| Rollins Brook Community Hospital | Lampasas, TX | Hospital |
| Adventhealth Central Texas | Killeen, TX | Hospital |
| Baylor Scott & White Pavilion - Temple | Temple, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ascension Seton | 5193634293 | 50 |
News Archive
Blood samples from more than 220 ALS patients at the Methodist Neurological Institute were used in research that revealed significant changes in or around 10 specific genes in sporadic ALS, the most common form of ALS.
Pfizer Inc. announced today that the Phase 3 AXIS 1032 trial (A4061032), studying the investigational compound axitinib in previously treated patients with metastatic renal cell carcinoma (mRCC), has met its primary endpoint, demonstrating that axitinib significantly extended progression-free survival when compared to sorafenib, in the study population.
A lean "Supermodel" mouse type has revealed the potentially critical role played by a largely unknown gene that regulates metabolism, findings that could provide new insight into diseases ranging from diabetes to obesity, a new study by UT-Southwestern Medical Center researchers suggests.
While news emerges regarding Tenet's plan to acqure Vanguard Health for $1.73 billion, the Ford Motor Co. announces its plans to launch a two-year health management program.
Many jobs, medical and otherwise, might one day be performed using artificial intelligence.
› Verified 4 days ago
| Entity Name | Ascension Seton |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073536900 PECOS PAC ID: 5193634293 Enrollment ID: O20031126000173 |
News Archive
Blood samples from more than 220 ALS patients at the Methodist Neurological Institute were used in research that revealed significant changes in or around 10 specific genes in sporadic ALS, the most common form of ALS.
Pfizer Inc. announced today that the Phase 3 AXIS 1032 trial (A4061032), studying the investigational compound axitinib in previously treated patients with metastatic renal cell carcinoma (mRCC), has met its primary endpoint, demonstrating that axitinib significantly extended progression-free survival when compared to sorafenib, in the study population.
A lean "Supermodel" mouse type has revealed the potentially critical role played by a largely unknown gene that regulates metabolism, findings that could provide new insight into diseases ranging from diabetes to obesity, a new study by UT-Southwestern Medical Center researchers suggests.
While news emerges regarding Tenet's plan to acqure Vanguard Health for $1.73 billion, the Ford Motor Co. announces its plans to launch a two-year health management program.
Many jobs, medical and otherwise, might one day be performed using artificial intelligence.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Georgia Catherine Hay, MD 1205 Central Texas Expy, Lampasas, TX 76550-3388 Ph: (512) 556-5362 | Georgia Catherine Hay, MD 1205 Central Texas Expy, Lampasas, TX 76550-3388 Ph: (512) 565-5362 |
News Archive
Blood samples from more than 220 ALS patients at the Methodist Neurological Institute were used in research that revealed significant changes in or around 10 specific genes in sporadic ALS, the most common form of ALS.
Pfizer Inc. announced today that the Phase 3 AXIS 1032 trial (A4061032), studying the investigational compound axitinib in previously treated patients with metastatic renal cell carcinoma (mRCC), has met its primary endpoint, demonstrating that axitinib significantly extended progression-free survival when compared to sorafenib, in the study population.
A lean "Supermodel" mouse type has revealed the potentially critical role played by a largely unknown gene that regulates metabolism, findings that could provide new insight into diseases ranging from diabetes to obesity, a new study by UT-Southwestern Medical Center researchers suggests.
While news emerges regarding Tenet's plan to acqure Vanguard Health for $1.73 billion, the Ford Motor Co. announces its plans to launch a two-year health management program.
Many jobs, medical and otherwise, might one day be performed using artificial intelligence.
› Verified 4 days ago
Dr. Raymond Gebhart Spaw, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1205 Central Texas Expy, Lampasas, TX 76550 Phone: 512-556-5362 Fax: 512-556-8004 | |
Dr. Mark S. Lane, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 187 Pr 4060, Lampasas, TX 76550 Phone: 512-556-3621 Fax: 512-556-6594 | |
Dr. Thomas Karl Kerley, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 602 N Key Ave, Lampasas, TX 76550 Phone: 512-556-3682 | |
Dr. Stephen Robert Vogel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 187 Pr 4060, Lampasas, TX 76550 Phone: 512-556-3621 Fax: 512-556-4080 | |
Dr. James E. Cain Iii, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 187 Pr 4060, Lampasas, TX 76550 Phone: 512-556-3621 Fax: 512-556-6594 | |
Reagan Duncan, APRN Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 187 Pr 4060, Lampasas, TX 76550 Phone: 512-556-3621 | |
Dr. Morris K Patteson Jr., MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 187 Private Road 4060, Lampasas, TX 76550 Phone: 512-556-3621 Fax: 512-556-6594 |